查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1425001

疾病控制和预防疫苗市场，按产品类型、给药途径、适应症、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Disease Control And Prevention Vaccine Market, By Product Type, By Route of administration, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 265 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年疾病管制与预防疫苗市场规模为512.103亿美元，2024年至2032年复合CAGR为10.5%。

疾管疫苗市场-市场动态

全球传染病发病率的上升和疫苗的采用预计将推动疾病控制和预防疫苗市场的扩大。

全球传染病发生率呈上升趋势，疫苗的使用有望在控制和预防其传播方面发挥重要作用。疫苗对于保障公众健康至关重要，随着人们对其重要性的认识不断提高，全世界越来越多地采用疫苗接种计划。政府、医疗机构和个人正在认识到疫苗在保护社区免受传染病负担方面的价值。纵观历史，传染病给人们带来了巨大的痛苦，无论是疾病或死亡。根据疾病管制与预防中心的数据，有 1,020 万人次因传染病和寄生虫病就诊，有 380 万人次以这些疾病为初步诊断而去急诊室就诊。疫苗技术的持续研究和开发为市场成长带来了光明的前景。然而，值得注意的是，严格的监管程序可能会对疾病管制和预防疫苗市场的扩张构成挑战。

疾病管制与预防疫苗市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 10.5% 左右的CAGR成长

根据产品类型细分，预计减毒活疫苗将在 2023 年占据最大市场份额

根据给药途径细分，注射剂是 2023 年的主导类型

依适应症细分，2023年传染病为主导类型

按地区划分，北美是 2023 年的主要收入来源

疾病管制与预防疫苗市场-細項分析：

全球疾病控制和预防疫苗市场根据产品类型、给药途径、适应症和地区进行细分。

市场依产品类型分为四大类：减毒活疫苗、灭活疫苗、重组疫苗和类毒素疫苗。减毒活疫苗占据了市场的很大一部分。这些疫苗以其卓越的有效性而闻名，它们非常模仿自然感染，提供强大而持久的免疫力。

根据给药途径，市场分为两类：口服和注射。注射剂市场占据了很大一部分市场。注射疫苗透过注射（通常是肌肉注射（IM）或皮下注射（SC））来刺激免疫系统并引发免疫反应。

市场依适应症分为两类：传染病、癌症和其他适应症。传染病领域对市场有重大影响力。许多国家实施免疫计划来控制传染病的传播。这些计划通常包括常规儿童疫苗接种和针对特定族群的针对性疫苗接种。

疾病管制与预防疫苗市场-地理洞察

从地理来看，该市场遍布北美、拉丁美洲、欧洲、亚太、中东和非洲等多个地区。这些区域根据参与商业活动的国家进一步划分。在预测期内，市场成长预计将由北美推动，这主要是由于高度先进技术的可用性和创新疫苗的持续开发。北美，尤其是美国，以其先进的医疗基础设施和研究能力而闻名。该地区拥有众多製药和生物技术公司，这些公司大力投资研发，从而开发了疫苗生产的尖端技术。 2022年底，美国预计将在医疗保健方面支出4.5兆美元，成为全球医疗保健整体支出最高的国家。根据美国医疗保健最新资料和报告，2021年该国总体支出预计将达到4.3兆美元，占GDP的18.5%。欧洲是预测期内市场成长的第二大地区，这主要是由于疾病负担的增加。

疾病管制与预防疫苗市场-竞争格局：

疾病管制与预防疫苗市场涵盖各种组织和公司开发的各种用于对抗不同疾病的疫苗。疫苗进步的显着贡献者包括世界卫生组织 (WHO)、美国国立卫生研究院 (NIH) 和私人实体。最近出现的传染病规模空前，为疫苗开发商、监管机构、卫生当局和政治选民带来了新的挑战。疫苗的生产和分销是一个复杂的过程，需要快速并仔细考虑临床开发、紧急使用授权、疫苗安全监测和病毒变种监测。优先考虑低收入和中等收入国家的疫苗取得和疫苗接种工作至关重要。虽然疫苗行业与製药行业相比规模较小，但正在稳步增长。疫苗产业内的公司从事疫苗的研究、开发、製造、销售、行销和分销，其收入主要来自疫苗产品销售。

最新进展：

据辉瑞公司称，2023 年10 月，FDA 批准了PENBRAYA（脑膜炎球菌A、B、C、W 和Y 群疫苗）。这是第一个也是唯一一个五价疫苗，可以预防引起脑膜炎双球菌疾病最常见的血清群。青少年和年轻人（10-25 岁）。为了帮助预防导致全球大多数侵袭性脑膜炎球菌疾病(IMD) 的五种最常见脑膜炎双球菌血清群，PENBRAYA 结合了两种脑膜炎双球菌疫苗的成分：Nimenrix (R)（脑膜炎双球菌群A、 C、W-135 和Y 结合疫苗）和 Trumenba (R)（B 型脑膜炎双球菌疫苗）。

目录

第一章：疾病管制与预防疫苗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的疾病管制与预防疫苗市场片段
    • 按给药途径分類的疾病管制与预防疫苗市场片段
    • 疾病管制与预防疫苗市场片段（按适应症）
    • 按国家/地区分類的疾病管制与预防疫苗市场片段
    • 按地区分類的疾病管制与预防疫苗市场片段
  • 竞争洞察

第 3 章：疾病管制与预防疫苗主要市场趋势

  • 疾病管制与预防疫苗市场驱动因素
    • 市场驱动因素的影响分析
  • 疾病管制与预防疫苗市场限制
    • 市场限制影响分析
  • 疾病管制与预防疫苗市场机会
  • 疾病预防控制疫苗市场未来趋势

第四章：疾病预防控制疫苗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：疾病管制与预防疫苗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：疾病管制与预防疫苗市场格局

  • 2023年疾病管制与预防疫苗市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：疾病管制与预防疫苗市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 减毒活疫苗
    • 灭活疫苗
    • 重组疫苗
    • 类毒素疫苗

第 8 章：疾病管制与预防疫苗市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市占率分析
    • 口服
    • 可注射

第 9 章：疾病管制与预防疫苗市场 - 按适应症

  • 概述
    • 按指标分類的细分市场占有率分析
    • 传染病
    • 癌症
    • 其他指示

第 10 章：疾病管制与预防疫苗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美疾病管制与预防疫苗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模与预测（按管理途径）
    • 北美市场规模和预测（按指标）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲疾病管制与预防疫苗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模与预测（按管理途径）
    • 欧洲市场规模与预测（按指标）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区疾病管制与预防疫苗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（依管理途径）
    • 亚太地区市场规模与预测（依指标）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲疾病管制与预防疫苗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 拉丁美洲市场规模与预测（按指标）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲疾管疫苗主要生产商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模和预测（按管理途径）
    • 中东和非洲市场规模及预测（依指标）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第11章：疾病预防疫苗产业主要供应商分析

  • 竞争仪表板
  • 公司简介
    • Merck & Co. GlaxoSmithKline plc.
    • Sanofi, AstraZeneca PLC
    • Pfizer Inc.
    • Astellas Pharma Inc.
    • Sinovac Biotech Ltd.
    • Daiichi Sankyo
    • Serum Institute of India Pvt. Ltd.

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2201

REPORT HIGHLIGHT

Disease Control And Prevention Vaccine Market size was valued at USD 51,210.3 Million in 2023, expanding at a CAGR of 10.5% from 2024 to 2032.

Immunization is widely recognized as a significant achievement in public health throughout the twentieth century. Vaccines have proven to be highly effective in preventing diseases, saving lives, and reducing healthcare costs. The widespread adoption of vaccination has successfully prevented disability and death in numerous children, leading governments worldwide to prioritize vaccination in their public health services. China, for instance, has effectively controlled infectious diseases through its national immunization program, which is based on vaccination. The Centers for Disease Control and Prevention (CDC) plays a crucial role in recommending and promoting vaccination programs to protect individuals and communities from vaccine-preventable diseases. The CDC provides vaccination guidelines, monitors vaccine safety, conducts research on vaccine effectiveness, and collaborates with other organizations to ensure a comprehensive approach to disease prevention.

Disease Control And Prevention Vaccine Market- Market Dynamics

Rising incidence of infectious diseases worldwide and the adoption of vaccines are anticipated to propel the expansion of the Disease Control and Prevention Vaccine market.

The global incidence of infectious diseases is on the rise, and the use of vaccines is expected to play a significant role in controlling and preventing their spread. Vaccines are crucial in safeguarding public health, and as awareness about their importance increases, there is a growing adoption of vaccination programs worldwide. Governments, healthcare organizations, and individuals are recognizing the value of vaccines in protecting communities from the burden of infectious diseases. Throughout history, infectious diseases have caused immense suffering, both in terms of illness and death. According to the Center for Disease Control and Prevention, there were 10.2 million visits to physician offices for infectious and parasitic diseases, and 3.8 million emergency department visits with these diseases as the primary diagnosis. Ongoing research and development in vaccine technology hold promising prospects for market growth. However, it is important to note that stringent regulatory processes may pose challenges to the expansion of the Disease Control and Prevention Vaccine market.

Disease Control And Prevention Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.5% over the forecast period (2024-2032)

Based on product type segmentation, Live-attenuated Vaccines was predicted to show maximum market share in the year 2023

Based on Route of administration segmentation, Injectable was the leading type in 2023

Based on Indication segmentation, Infectious Disease was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Disease Control And Prevention Vaccine Market- Segmentation Analysis:

The Global Disease Control And Prevention Vaccine Market is segmented on the basis of Product Type, Route of administration, Indication, and Region.

The market is divided into four categories based on product type: Live-attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines and Toxoid Vaccines. Live-attenuated vaccines dominate a substantial portion of the market. Renowned for their remarkable effectiveness, these vaccines closely mimic natural infections, providing robust and long-lasting immunity.

The market is divided into two categories based on Route of administration: Oral and Injectable. The injectable segment commands a substantial portion of the market. Injectable vaccines are delivered through injections, typically either intramuscularly (IM) or subcutaneously (SC), to stimulate the immune system and initiate an immune response.

The market is divided into two categories based on Indication: Infectious Disease, Cancer and Other Indication. The Infectious Disease segment holds significant sway over the market. Many nations implement immunization programs to control the spread of infectious diseases. These programs often include routine childhood vaccinations and targeted vaccinations for specific populations.

Disease Control And Prevention Vaccine Market- Geographical Insights

Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The market growth is expected to be driven by North America in the forecast period, primarily due to the availability of highly advanced technologies and the increasing development of innovative vaccines. North America, especially the United States, is renowned for its advanced healthcare infrastructure and research capabilities. The region is home to numerous pharmaceutical and biotechnology companies that heavily invest in research and development, leading to the development of cutting-edge technologies for vaccine production. By the end of 2022, the United States is projected to spend USD 4.5 trillion on healthcare, making it the country with the highest overall healthcare expenditure globally. According to the latest data and reports on healthcare in the United States, the country's overall spending in 2021 is estimated to reach USD 4.3 trillion, accounting for 18.5% of its GDP. Europe holds the second-largest region for market growth during the forecast period, primarily due to the increasing disease burden.

Disease Control And Prevention Vaccine Market- Competitive Landscape:

The Disease Control and Prevention Vaccine market encompasses a wide range of vaccines developed by various organizations and companies to combat different diseases. Notable contributors to vaccine advancements include the World Health Organization (WHO), National Institutes of Health (NIH), and private entities. The recent emergence of infectious diseases on an unprecedented scale has presented new challenges for vaccine developers, regulators, health authorities, and political constituencies. The manufacturing and distribution of vaccines are complex processes that require both speed and careful consideration of clinical development, emergency use authorization, vaccine safety monitoring, and surveillance of virus variants. It is crucial to prioritize access to vaccines and vaccination efforts in low- and middle-income countries. While the vaccine industry is smaller compared to the pharmaceutical industry, it is steadily growing. Companies within the vaccine industry engage in research, development, manufacturing, sales, marketing, and distribution of vaccines, with their revenue primarily derived from vaccine product sales.

Recent Development:

In October 2023, the FDA has approved PENBRAYA (meningococcal groups A, B, C, W, and Y vaccine), according to Pfizer Inc. This is the first and only pentavalent vaccine that protects against the most common serogroups that cause meningococcal disease in adolescents and young adults (10-25 years of age). In order to help protect against the five most common meningococcal serogroups that cause the majority of invasive meningococcal disease (IMD) worldwide, PENBRAYA combines the components from two meningococcal vaccines: Nimenrix® (meningococcal groups A, C, W-135, and Y conjugate vaccine) and Trumenba® (meningococcal group B vaccine).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Merck & Co. GlaxoSmithKline plc.

Sanofi, AstraZeneca PLC

Pfizer Inc.

Astellas Pharma Inc.

Sinovac Biotech Ltd.

Daiichi Sankyo

Serum Institute of India Pvt. Ltd.

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Live-attenuated Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injectable

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Disease
  • Cancer
  • Other Indication

GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Disease Control And Prevention Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Disease Control And Prevention Vaccine Market Snippet by Product Type
    • 2.1.2. Disease Control And Prevention Vaccine Market Snippet by Route of administration
    • 2.1.3. Disease Control And Prevention Vaccine Market Snippet by Indication
    • 2.1.4. Disease Control And Prevention Vaccine Market Snippet by Country
    • 2.1.5. Disease Control And Prevention Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Disease Control And Prevention Vaccine Key Market Trends

  • 3.1. Disease Control And Prevention Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Disease Control And Prevention Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Disease Control And Prevention Vaccine Market Opportunities
  • 3.4. Disease Control And Prevention Vaccine Market Future Trends

4. Disease Control And Prevention Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Disease Control And Prevention Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Disease Control And Prevention Vaccine Market Landscape

  • 6.1. Disease Control And Prevention Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Disease Control And Prevention Vaccine Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Live-attenuated Vaccines
    • 7.1.3. Inactivated Vaccines
    • 7.1.4. Recombinant Vaccines
    • 7.1.5. Toxoid Vaccines

8. Disease Control And Prevention Vaccine Market - By Route of administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of administration, 2023 & 2032 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectable

9. Disease Control And Prevention Vaccine Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2. Infectious Disease
    • 9.1.3. Cancer
    • 9.1.4. Other Indication

10. Disease Control And Prevention Vaccine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Disease Control And Prevention Vaccine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Disease Control And Prevention Vaccine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Disease Control And Prevention Vaccine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Disease Control And Prevention Vaccine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Disease Control And Prevention Vaccine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of administration, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Disease Control And Prevention Vaccine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Merck & Co. GlaxoSmithKline plc.
    • 11.2.2. Sanofi, AstraZeneca PLC
    • 11.2.3. Pfizer Inc.
    • 11.2.4. Astellas Pharma Inc.
    • 11.2.5. Sinovac Biotech Ltd.
    • 11.2.6. Daiichi Sankyo
    • 11.2.7. Serum Institute of India Pvt. Ltd.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Disease Control And Prevention Vaccine Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Disease Control And Prevention Vaccine Market, by Product Type 2019-2032 (USD Million)
  • TABLE Disease Control And Prevention Vaccine Market: Route of administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Route of administration
  • TABLE Global Disease Control And Prevention Vaccine Market, by Route of administration 2019-2032 (USD Million)
  • TABLE Disease Control And Prevention Vaccine Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Disease Control And Prevention Vaccine Market, by Indication 2019-2032 (USD Million)
  • TABLE Disease Control And Prevention Vaccine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Disease Control And Prevention Vaccine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE North America Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE Europe Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE Latin America Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Disease Control And Prevention Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Disease Control And Prevention Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Disease Control And Prevention Vaccine Market, by Route of administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Disease Control And Prevention Vaccine Market, by Indication, 2019-2032 (USD Million)

List of Figures

  • FIGURE Disease Control And Prevention Vaccine Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Route of administration segment market share analysis, 2023 & 2032
  • FIGURE Route of administration segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indication segment market share analysis, 2023 & 2032
  • FIGURE Indication segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE Europe Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE Asia Pacific Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE Latin America Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE Middle East and Africa Disease Control And Prevention Vaccine Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Disease Control And Prevention Vaccine Market share analysis by country, 2023
  • FIGURE Germany Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Disease Control And Prevention Vaccine Market share analysis by country, 2023
  • FIGURE India Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Disease Control And Prevention Vaccine Market share analysis by country, 2023
  • FIGURE Brazil Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Disease Control And Prevention Vaccine Market share analysis by country, 2023
  • FIGURE Saudi Arabia Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Disease Control And Prevention Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)